| NANOREPRO AG |
| Deutschland |
| Gesundheit |
| DE0006577109 / 657710 |
| NN6 (Frankfurt) |
| FRA:NN6, ETR:NN6, NN6:GR |
| - |
| http://www.nanorepro.com/ |
|
NanoRepro AG is a biotechnology company that specializes in the development, manufacturing, and distribution of rapid diagnostic tests. These tests are primarily used in personal and home care health sectors. NanoRepro's portfolio includes products t..
>Volltext.. |
| 19.62 Mio. EUR |
| 12.4 Mio. EUR |
| 5.22 Mio. EUR |
| -2.19 Mio. EUR |
| -1.76 Mio. EUR |
| -0.14 EUR |
| - |
| 7.42 Mio. EUR |
| 2.89 Mio. EUR |
| 23.2 |
| 43.88% |
| 46.12% |
| - |
| - |
| - |
| 16.06.23 - 0.15€ 02.05.22 - 0.5€ |
| - |
| NANOREPRO |
| 02.04.26 |
|